I'm Vita Ranks No. 1 in KMAC Korea Brand Power for 3 Consecutive Years, Strengthening Its Position in the Vitamin Market View original image

I'm Vita, the vitamin brand of Chong Kun Dang Healthcare, has been ranked No. 1 in the vitamin category in the "2026 Korea Brand Power Index (K-BPI)" survey conducted by Korea Management Association Consulting (KMAC).


With this achievement, I'm Vita has maintained its top position in the category for three consecutive years from 2024 to 2026, further solidifying its presence in the market. The Korea Brand Power Index is an indicator that comprehensively evaluates brand awareness, trust, and loyalty to measure competitiveness.


I'm Vita has been managing its brand with a focus on product design based on premium ingredients and a balanced blend of nutrients. The company is expanding its product lineup to simultaneously reflect both functionality and ease of consumption, taking into account the diverse lifestyles of consumers.


The flagship product, "I'm Vita Multivitamin Immune Shot," is an all-in-one type that combines liquid and tablet forms, providing comprehensive nutrition in a single serving. It uses European-sourced vitamin ingredients from DSM and contains a total of 18 nutrients, including 10 types of vitamins, 7 types of minerals, and beta-carotene.


In particular, the product is characterized by its high content of B vitamins, designed with the modern, multi-tasking lifestyle in mind, focusing on supporting daily energy metabolism. Since its launch, cumulative sales of this product have exceeded 50 million bottles.



A representative from Chong Kun Dang Healthcare explained that this No. 1 ranking is especially meaningful as it is based on actual consumer evaluations. The company also stated that it will continue to pursue quality ingredients and optimal blends to further enhance product competitiveness in the future.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing